Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03761121 · ClinicalTrials.gov registry record · NA
Developing Fast Pediatric Imaging
A NA study of Pediatric Low-grade Gliomas, sponsored by Boston Children's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 3
- Study locations
NCT03761121 is a NA study of Pediatric Low-grade Gliomas that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 300 participants. The trial reports 3 study locations across 1 state.
The verdict
NCT03761121, a NA study of Pediatric Low-grade Gliomas, is actively recruiting participants, sponsored by Boston Children's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 3
- Study locations
Study Summary
This research study is evaluating the investigational software for magnetic resonance imaging (MRI) systems and techniques to process magnetic resonance (MR) images
Conditions Studied
Interventions
- OTHER Wave-CAIPI
Study Locations (3)
Massachusetts
- Massachusetts General Hospital - Boston
- Boston Children Hospital - Boston
- Dana Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2019-04-15 |
| Est. Completion | 2028-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03761121
The ClinicalTrials.gov registry entry for NCT03761121 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pediatric Low-grade Gliomas appearing as the primary indexed condition, and to 1 intervention - of which Wave-CAIPI is the first listed.
NCT03761121 reports 3 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03761121 about?
NCT03761121 is a clinical study titled "Developing Fast Pediatric Imaging". This research study is evaluating the investigational software for magnetic resonance imaging (MRI) systems and techniques to process magnetic resonance (MR) images
What is the current status of trial NCT03761121?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2019-04-15. Estimated completion is 2028-03-01.
What conditions does trial NCT03761121 study?
This clinical trial studies the following conditions: Pediatric Low-grade Gliomas.
What interventions are being tested in trial NCT03761121?
The interventions under investigation include: Wave-CAIPI (OTHER).
Who is sponsoring clinical trial NCT03761121?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03761121 being conducted?
This trial has 3 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.